Section

Supplementary Review: Avanos Medical (AVNS), November 1, 2023

one year ago Market forbes
Q3 net sales from continuing operations fell 0.6% year-over-year to $171.3 million. Sales from its Digestive Health franchise grew by 10.6% to $95.0 million on [...] Read more at: forbes

Tags : FORR Supplementary Review: Avanos Medical AVNS EBITDA Recovery

Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Bollywood charcha does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.

You May Also Like